Login / Signup

Scoping review of costs of implementation strategies in community, public health and healthcare settings.

Tzeyu L MichaudEmiliane PereiraGwenndolyn PorterCaitlin GoldenJennie HillJungyoon KimHongmei WangCindy SchmidtPaul A Estabrooks
Published in: BMJ open (2022)
The quantity of published D&I strategy cost analyses is increasing, yet guidance on conducting and reporting of D&I strategy cost analysis is necessary to facilitate and promote the application of comparative economic evaluation in the field of D&I research.
Keyphrases
  • healthcare
  • public health
  • primary care
  • mental health
  • adverse drug
  • systematic review
  • quality improvement